Market Cap 263.93M
Revenue (ttm) 33.48M
Net Income (ttm) -52.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -157.41%
Debt to Equity Ratio 0.27
Volume 474,900
Avg Vol 223,988
Day's Range N/A - N/A
Shares Out 58.52M
Stochastic %K 69%
Beta 0.56
Analysts Strong Sell
Price Target $12.57

Company Profile

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications;...

Industry: Biotechnology
Sector: Healthcare
Phone: 215 862 5797
Address:
150 Union Square Drive, New Hope, United States
Jordan3333
Jordan3333 Mar. 20 at 8:12 AM
$OBIO fantastic accumulation going on in last couple of days, when the market turns $OBIO will go above 5 like nothing
0 · Reply
Deeppan
Deeppan Mar. 16 at 9:59 PM
$OBIO the stock is under definite accumulation, it will probably go back to the Russell later this spring, and multi millions of shares will have to be acquired for that to happen. It is still in the bargain class as we speak, but slowly, but surely it’ll start creeping up. After being in the doghouse for quite a while, things are moving again, and the trend will be our friends. Don’t wait.
1 · Reply
Mptxop
Mptxop Mar. 12 at 2:48 PM
$OBIO going back to 3.50$
0 · Reply
ChefBoyAreWeGonnaBeRich
ChefBoyAreWeGonnaBeRich Mar. 12 at 11:50 AM
0 · Reply
Lambster2
Lambster2 Mar. 11 at 4:16 PM
$OBIO Orchestra BioMed (NASDAQ: OBIO) Buy (1) ESG Score: 67/100 Price Target: $15.00 Orchestra BioMed Has A Catalyst-Rich Pipeline with Underappreciated Value THE TD COWEN INSIGHT After OBIO management presented at the TD Cowen Health Care Conference last week, we more fully recognized that 2026-2027 are catalyst rich years and significant value creation drivers are in play. In this report, we highlight the progress and upcoming milestones for the two major clinical development programs. Reiterate Buy.
0 · Reply
KardiTheViking
KardiTheViking Mar. 5 at 11:09 AM
$OBIO why does it show $0.00 here? They want to give an heart attack to people
1 · Reply
Lambster2
Lambster2 Mar. 3 at 6:12 PM
$OBIO Volume over 1M Technically breaking out Great presentation today
0 · Reply
Lambster2
Lambster2 Mar. 3 at 2:52 PM
$OBIO Wow, look at the volume on mews. Very bullish
0 · Reply
FredBerendsen13
FredBerendsen13 Feb. 26 at 8:26 AM
$OBIO Orchestra BioMed Holdings: Well-Funded To Complete Enrollment of Two Pivotal Trials And Well-Partnered For Commercialization Nice coverage. Terumo, Medtronic and Ligand partnerships could be recipe for success. $MDT $LGND $XBI Link to coverage in reply.
2 · Reply
Lambster2
Lambster2 Feb. 25 at 6:25 PM
$OBIO Nice move today. Two conferences in March. Think we see five in the coming 3-4 weeks.
0 · Reply
Latest News on OBIO
Orchestra BioMed Announces Proposed Public Offering

Jul 31, 2025, 4:02 PM EDT - 8 months ago

Orchestra BioMed Announces Proposed Public Offering


Orchestra BioMed to Present at Upcoming Investor Conferences

Feb 20, 2025, 8:00 AM EST - 1 year ago

Orchestra BioMed to Present at Upcoming Investor Conferences


Jordan3333
Jordan3333 Mar. 20 at 8:12 AM
$OBIO fantastic accumulation going on in last couple of days, when the market turns $OBIO will go above 5 like nothing
0 · Reply
Deeppan
Deeppan Mar. 16 at 9:59 PM
$OBIO the stock is under definite accumulation, it will probably go back to the Russell later this spring, and multi millions of shares will have to be acquired for that to happen. It is still in the bargain class as we speak, but slowly, but surely it’ll start creeping up. After being in the doghouse for quite a while, things are moving again, and the trend will be our friends. Don’t wait.
1 · Reply
Mptxop
Mptxop Mar. 12 at 2:48 PM
$OBIO going back to 3.50$
0 · Reply
ChefBoyAreWeGonnaBeRich
ChefBoyAreWeGonnaBeRich Mar. 12 at 11:50 AM
0 · Reply
Lambster2
Lambster2 Mar. 11 at 4:16 PM
$OBIO Orchestra BioMed (NASDAQ: OBIO) Buy (1) ESG Score: 67/100 Price Target: $15.00 Orchestra BioMed Has A Catalyst-Rich Pipeline with Underappreciated Value THE TD COWEN INSIGHT After OBIO management presented at the TD Cowen Health Care Conference last week, we more fully recognized that 2026-2027 are catalyst rich years and significant value creation drivers are in play. In this report, we highlight the progress and upcoming milestones for the two major clinical development programs. Reiterate Buy.
0 · Reply
KardiTheViking
KardiTheViking Mar. 5 at 11:09 AM
$OBIO why does it show $0.00 here? They want to give an heart attack to people
1 · Reply
Lambster2
Lambster2 Mar. 3 at 6:12 PM
$OBIO Volume over 1M Technically breaking out Great presentation today
0 · Reply
Lambster2
Lambster2 Mar. 3 at 2:52 PM
$OBIO Wow, look at the volume on mews. Very bullish
0 · Reply
FredBerendsen13
FredBerendsen13 Feb. 26 at 8:26 AM
$OBIO Orchestra BioMed Holdings: Well-Funded To Complete Enrollment of Two Pivotal Trials And Well-Partnered For Commercialization Nice coverage. Terumo, Medtronic and Ligand partnerships could be recipe for success. $MDT $LGND $XBI Link to coverage in reply.
2 · Reply
Lambster2
Lambster2 Feb. 25 at 6:25 PM
$OBIO Nice move today. Two conferences in March. Think we see five in the coming 3-4 weeks.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 9:26 PM
$OBIO Current Stock Price: $4.04 Contracts to trade: $2.5 OBIO Mar 20 2026 Call Entry: $1.05 Exit: $1.48 ROI: 41% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 21 at 1:27 PM
$OBIO RSI: 60.59, MACD: -0.0727 Vol: 0.16, MA20: 3.92, MA50: 4.19 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JenniferPeters614
JenniferPeters614 Feb. 21 at 7:27 AM
$OBIO Orchestra BioMed develops cardiovascular therapies. Clinical outcomes drive valuation. Early-stage risk remains high.
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 9:33 AM
$OBIO Great piece that accurately captures OBIO's current position. So if you want to refresh your understanding of OBIO or learn about OBIO for the first time, this is essential reading. https://everyticker.com/quote/OBIO/analysis/orchestra-biomed-orchestrating-future-growth-through-breakthrough-technologies-and-strategic-alliances-nasdaq-obio
0 · Reply
Pkinla
Pkinla Feb. 2 at 8:03 PM
$OBIO what’s cooking!? Don’t see any news !
0 · Reply
Lambster2
Lambster2 Feb. 2 at 6:34 PM
$OBIO Nice move. On to 5
0 · Reply
topstockalerts
topstockalerts Feb. 2 at 5:31 PM
$OBIO Interesting spot for a momentum swing 💡. Price is holding strength. Buyers are clearly engaged.
0 · Reply
Mptxop
Mptxop Jan. 30 at 7:53 PM
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 8:17 PM
$OBIO RSI: 43.86, MACD: -0.0874 Vol: 0.27, MA20: 4.31, MA50: 4.44 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Lambster2
Lambster2 Jan. 26 at 3:11 PM
$OBIO Adding here under 4
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst Jan. 23 at 8:01 PM
$LUCD here comes the start of the real move $RMCO $WWR $OBIO The yr of the small caps
1 · Reply
Mptxop
Mptxop Jan. 13 at 9:08 PM
$OBIO They get 21 million to the books and it sinks? Wild times!
0 · Reply